276 related articles for article (PubMed ID: 15075621)
41. A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing.
Carriero D; Aberman J; Lin SY; Hill A; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 1998 May; 137(2):147-56. PubMed ID: 9630001
[TBL] [Abstract][Full Text] [Related]
42. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
Drews E; Schneider M; Koch M
Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
[TBL] [Abstract][Full Text] [Related]
43. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
[TBL] [Abstract][Full Text] [Related]
44. Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.
Hruba L; Ginsburg BC; McMahon LR
J Pharmacol Exp Ther; 2012 Sep; 342(3):843-9. PubMed ID: 22718500
[TBL] [Abstract][Full Text] [Related]
45. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
46. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
47. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.
Rawls SM; Cowan A; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):395-402. PubMed ID: 12235276
[TBL] [Abstract][Full Text] [Related]
48. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 Sep; 14(5-6):471-6. PubMed ID: 14501260
[TBL] [Abstract][Full Text] [Related]
49. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
[TBL] [Abstract][Full Text] [Related]
50. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
Ottani A; Leone S; Sandrini M; Ferrari A; Bertolini A
Eur J Pharmacol; 2006 Feb; 531(1-3):280-1. PubMed ID: 16438952
[TBL] [Abstract][Full Text] [Related]
51. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
52. Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats.
Khasabova IA; Simone DA; Seybold VS
Neuroscience; 2002; 115(2):613-25. PubMed ID: 12421626
[TBL] [Abstract][Full Text] [Related]
53. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
Rawls SM; Cabassa J; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
[TBL] [Abstract][Full Text] [Related]
54. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
55. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
56. Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
Svensson AC; Johansson M; Persson E; Carchenilla MS; Jacobsson SO
J Neurosci Res; 2006 May; 83(6):1128-40. PubMed ID: 16477621
[TBL] [Abstract][Full Text] [Related]
57. Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy.
Rawls SM; Tallarida RJ; Zisk J
Eur J Pharmacol; 2006 Dec; 553(1-3):89-98. PubMed ID: 17109846
[TBL] [Abstract][Full Text] [Related]
58. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
59. Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
Kwilasz AJ; Negus SS
J Pharmacol Exp Ther; 2012 Nov; 343(2):389-400. PubMed ID: 22892341
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]